ASYN has also been implicated in other proteinopathies such as familial Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB), in which pathogenic tau species (e.g. hyperphosphorylated forms or pTau) are believed to contribute to these conditions. The gene discussed is MAPT; the disease is familial Alzheimer disease.